AAP
ALBO

Ardsley Advisory Partners’s Albireo Pharma Inc ALBO Stock Holding History

Ardsley Advisory Partners’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7,600
Closed -$245K – 186
2019
Q1 		$245K Sell
7,600
-2,500
-25% -$67.3K 0.05% 110
2018
Q4 		$248K Hold
10,100
– – 0.06% 88
2018
Q3 		$333K Sell
10,100
-5,000
-33% -$164K 0.04% 121
2018
Q2 		$536K Sell
15,100
-1,000
-6% -$32.4K 0.08% 106
2018
Q1 		$535K Buy
16,100
+4,800
+42% +$162K 0.08% 97
2017
Q4 		$289K Buy
+11,300
New +$287K 0.04% 117

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Ardsley Advisory Partners's ALBO Position: Q2 2019 in Review

Ardsley Advisory Partners sold out of Albireo Pharma Inc (ALBO) in Q2 2019, closing a stake of 7,600 shares — an estimated $245K sold.

Ardsley Advisory Partners first reported a position in ALBO in Q4 2017 and held it in 6 quarters. The position peaked at $536K in Q2 2018. 74 funds tracked by Wall St. Rank hold ALBO as of Q2 2019.

  • Ardsley Advisory Partners reported no remaining Albireo Pharma Inc position as of Q2 2019 after selling out during the quarter.
  • Ardsley Advisory Partners sold 7,600 Albireo Pharma Inc shares in Q2 2019, an estimated $245K.
  • Ardsley Advisory Partners first reported a position in Albireo Pharma Inc in Q4 2017 and held it in 6 quarters.
  • Ardsley Advisory Partners's Albireo Pharma Inc position peaked at $536K in Q2 2018.
  • 74 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q2 2019.

Based on Ardsley Advisory Partners's 13F filing for Q2 2019, filed 13 Aug 2019.